Blood test could guide when to stop breast cancer treatment
NCT ID NCT06663787
Summary
This study is testing a personalized blood test to see if it can detect tiny traces of cancer in patients with advanced HER2-positive breast cancer who have responded very well to treatment for over two years. The goal is to gather knowledge that might help doctors decide if and when it's safe to reduce or stop maintenance therapy for these long-term responders. The study is not providing a new treatment but aims to inform future treatment strategies.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HER2 + BREAST CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Aichi Cancer Center
Nagoya, Aichi-ken, 4678601, Japan
-
Nagoya City University
Nagoya, Aichi-ken, 4678601, Japan
-
Natera
San Carlos, Texas, 94070, United States
-
The Cancer Institute Hospital of Japanese Foundation for Cancer Research
Tokyo, Tokyo, 135-8550, Japan
Conditions
Explore the condition pages connected to this study.